Albany Molecular Research Inc (NASDAQ:AMRI)

During the Trading Day
17.72 +0.12 / +0.68%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
17.72 0.00 / 0.00%
 
Volume: 17.2K
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$576.3M

Company Description

Albany Molecular Research, Inc. provides scientific services, technologies and products. It provides contract services platform encompassing drug discovery, development and manufacturing services. The company operates through three segments: Large Scale Manufacturing & Discovery and Drug Development & Small Scale Manufacturing. The Large Scale Manufacturing & Discovery Segment includes pilot to commercial scale production of active pharmaceutical ingredients and intermediates, sterile syringe and vial filling and high potency and controlled substance manufacturing. The Drug Development & Small Scale Manufacturing segment includes activities such as drug lead discovery, optimization, drug development and small scale commercial manufacturing. It operates in United States, Europe and Asia. The company was founded by Thomas E. D'Ambra on June 20, 1991 and is headquartered in Albany, NY.

Contact Information

Albany Molecular Research, Inc.
26 Corporate Circle
Albany New York 12203
P:(518) 512-2000
Investor Relations:

Employees

Shareholders

Other institutional62.24%
Mutual fund holders30.93%
Individual stakeholders28.66%

Top Executives

William S. MarthPresident, Chief Executive Officer & Director
Felicia LadinChief Financial Officer, Treasurer & Senior VP
Jimmy WangChief Information Officer
Lori M. HendersonSecretary, Senior Vice President & General Counsel
Richard A. SaffeeVice President & GM-Large Scale Manufacturing

To view my watchlist

Not a member yet?

Sign up now for a free account